Durability of Conventional Immunosuppressants in the Treatment of Oral Lichen Planus
{{output}}
Background: Oral lichen planus (OLP) is an inflammatory disease involving the oral mucosa. It affects roughly 0.5% to 2% of the global population and has an associated risk of oral squamous cell carcinoma. Treatment of moderate t... ...
